Compared with the normal tissues (p < 0.01, |log2 fold change| >1.5), we found that C1ORF112 was upregulated in almost all cancer types (Figure 1A), including colorectal cancer, breast cancer, lung cancer, sarcomas, and tumors of the CNS. Here, FIRRM is linked to sarcoma.